| pubmed-article:21508383 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21508383 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:21508383 | lifeskim:mentions | umls-concept:C0026473 | lld:lifeskim |
| pubmed-article:21508383 | lifeskim:mentions | umls-concept:C0079633 | lld:lifeskim |
| pubmed-article:21508383 | lifeskim:mentions | umls-concept:C0282554 | lld:lifeskim |
| pubmed-article:21508383 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
| pubmed-article:21508383 | lifeskim:mentions | umls-concept:C2700400 | lld:lifeskim |
| pubmed-article:21508383 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21508383 | pubmed:dateCreated | 2011-4-21 | lld:pubmed |
| pubmed-article:21508383 | pubmed:abstractText | Tumour-derived microvesicles (TMVs) may interact with cells of the immune system. Our previous observations indicated that TMVs modulate production of cytokines and reactive oxygen species (ROS) by monocytes. This study was designed to determine the role of TMVs in stimulation of chemokine production by human monocytes. | lld:pubmed |
| pubmed-article:21508383 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21508383 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21508383 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21508383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21508383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21508383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21508383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21508383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21508383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21508383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21508383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21508383 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21508383 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:21508383 | pubmed:issn | 1791-7530 | lld:pubmed |
| pubmed-article:21508383 | pubmed:author | pubmed-author:ZembalaMarekM | lld:pubmed |
| pubmed-article:21508383 | pubmed:author | pubmed-author:Baj-Krzyworze... | lld:pubmed |
| pubmed-article:21508383 | pubmed:author | pubmed-author:MytarBozennaB | lld:pubmed |
| pubmed-article:21508383 | pubmed:author | pubmed-author:BaranJaroslaw... | lld:pubmed |
| pubmed-article:21508383 | pubmed:author | pubmed-author:WeglarczykKaz... | lld:pubmed |
| pubmed-article:21508383 | pubmed:author | pubmed-author:SzatanekRafal... | lld:pubmed |
| pubmed-article:21508383 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21508383 | pubmed:volume | 31 | lld:pubmed |
| pubmed-article:21508383 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21508383 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21508383 | pubmed:pagination | 1329-35 | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:meshHeading | pubmed-meshheading:21508383... | lld:pubmed |
| pubmed-article:21508383 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21508383 | pubmed:articleTitle | Tumour-derived microvesicles contain interleukin-8 and modulate production of chemokines by human monocytes. | lld:pubmed |
| pubmed-article:21508383 | pubmed:affiliation | Department of Clinical Immunology, Jagiellonian University Medical College, Cracow, Poland. mibaj@cyf-kr.edu.pl | lld:pubmed |
| pubmed-article:21508383 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21508383 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
